Skip to main content
logo
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.040
-0.270 (-6.26%)
At close: Mar 27, 2026, 4:00 PM EDT
4.000
-0.040 (-0.99%)
After-hours: Mar 27, 2026, 4:37 PM EDT

X4 Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
35.112.56---
Revenue Growth (YoY)
1273.21%----
Cost of Revenue
5.760.8---
Gross Profit
29.361.76---
Selling, General & Admin
43.5261.5235.5127.0224.7
Research & Development
72.7281.6472.0261.0650.65
Other Operating Expenses
-105-0.519.76
Total Operating Expenses
116.24248.16107.5288.5985.11
Operating Income
-86.88-246.4-107.52-88.59-85.11
Interest Income
4.585.774.580.220.01
Interest Expense
-8.88-8.77-5.78-3.99-3.64
Other Non-Operating Income (Expense)
12.032.267.63-2.50.06
Total Non-Operating Income (Expense)
7.73-0.746.43-6.27-3.57
Pretax Income
-79.16-37.14-101.09-93.84-88.68
Provision for Income Taxes
0.040.310.080.030.02
Net Income
-79.2-37.45-101.17-91.32-74.75
Net Income Attributable to Preferred Dividends
---2.5513.94
Net Income to Common
-79.2-37.45-101.17-91.32-74.75
Shares Outstanding (Basic)
427621
Shares Outstanding (Diluted)
427621
Shares Change (YoY)
531.04%13.08%179.91%146.71%28.25%
EPS (Basic)
-1.87-5.59-17.07-45.60-119.70
EPS (Diluted)
-1.87-5.59-17.07-45.60-119.70
Shares Outstanding
90.915.75.584.060.94
Free Cash Flow
-85.62-131.23-96.57-77.21-71.52
Free Cash Flow Per Share
-2.02-19.58-16.29-36.46-83.33
Gross Margin
83.60%68.83%---
Operating Margin
-247.44%-9636.33%---
Profit Margin
-225.55%-1464.61%---
FCF Margin
-243.84%-5132.07%---
EBITDA
-85.61-245.61-107.1-88.07-84.61
EBITDA Margin
-243.80%-9605.20%---
EBIT
-86.88-246.4-107.52-88.59-85.11
EBIT Margin
-247.44%-9636.33%---
Effective Tax Rate
-0.05%-0.83%-0.08%-0.03%-0.02%
Updated Mar 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q